EV
Elikon Venture
Shanghai, ChinaFounded 2021
Elikon Venture is a seed to Series C stage investment firm based in Shanghai, China. It has made 4 investments, with focus areas including Biotech & Life Sciences. 100% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $50.2M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| FFortitude Biomedicines, Inc. | Seed | $13M | Jan 2026 |
 Angitia Biopharmaceuticals | Series C | $120M | Dec 2024 |
 Innovac Therapeutics | Series A | $18M | Sep 2023 |
| AAllorion Therapeutics | Series B | $50M | Mar 2023 |
Top Co-Investors
Lince Capital1 shared
TFX Capital1 shared
Vision Plus Capital1 shared
OrbiMed1 shared
Legend Capital1 shared
Last updated: 28 April 2026